Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | VP, SAM/CAM | March 05, 2018 | March 07, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date March 05, 2018 · Filed March 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,546 |
Ending reported balance
After 2018-03-05 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2018-03-05 · Exercise / conversion · Acquired 5,873 · Balance 9,636 F1: The reporting person received 2,783 shares of common stock upon the net exercise of the 5,873 stock appreciation rights ("SARs"). The reporting person forfeited 1,897 shares of common stock underlying the SARs in payment of the exercise price and 1,193 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27. Row 2 · 2018-03-05 · Disposition to issuer · Disposed 1,897 · Balance 7,739 F1: The reporting person received 2,783 shares of common stock upon the net exercise of the 5,873 stock appreciation rights ("SARs"). The reporting person forfeited 1,897 shares of common stock underlying the SARs in payment of the exercise price and 1,193 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27. Row 3 · 2018-03-05 · Tax withholding · Disposed 1,193 · Balance 6,546 F1: The reporting person received 2,783 shares of common stock upon the net exercise of the 5,873 stock appreciation rights ("SARs"). The reporting person forfeited 1,897 shares of common stock underlying the SARs in payment of the exercise price and 1,193 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $30.44 · Expires 2025-03-02 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-03-05 · Exercise / conversion · Disposed 5,873 · Balance 0 F1: The reporting person received 2,783 shares of common stock upon the net exercise of the 5,873 stock appreciation rights ("SARs"). The reporting person forfeited 1,897 shares of common stock underlying the SARs in payment of the exercise price and 1,193 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received 2,783 shares of common stock upon the net exercise of the 5,873 stock appreciation rights ("SARs"). The reporting person forfeited 1,897 shares of common stock underlying the SARs in payment of the exercise price and 1,193 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 1,840 | $6.82 | $12,548.80 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 7 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 127 | $72.81 | $9,246.87 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 6 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,365 F2 · kind: The reporting person received 295 shares of common stock upon the net exercise of the 600 SARs. The reporting person forfeited 178 shares of common stock underlying the SARS in payment of the exercise price and 127 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 178 | $72.81 | $12,960.18 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 5 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,492 F2 · kind: The reporting person received 295 shares of common stock upon the net exercise of the 600 SARs. The reporting person forfeited 178 shares of common stock underlying the SARS in payment of the exercise price and 127 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 600 | $21.57 | $12,942.00 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 4 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 782 | $72.81 | $56,937.42 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 3 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,070 F1 · kind: The reporting person received 1,822 shares of common stock upon the net exercise of the 3,600 stock appreciation rights ("SARS"). The reporting person forfeited 996 shares of common stock underlying the SARS in payment of the exercise price and 782 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 996 | $72.81 | $72,518.76 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 2 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,852 F1 · kind: The reporting person received 1,822 shares of common stock upon the net exercise of the 3,600 stock appreciation rights ("SARS"). The reporting person forfeited 996 shares of common stock underlying the SARS in payment of the exercise price and 782 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:35 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 3,600 | $20.14 | $72,504.00 |
DisclosureSEC source: 0001209191-17-031680 · doc4.xml · nonDerivative · entry 1 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:09 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 1,048 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014966 · doc4.xml · derivative · entry 2 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048 Underlying: Common Stock · 1,048 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 5,240 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 1,048 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:09 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 1,957 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014966 · doc4.xml · derivative · entry 1 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 Underlying: Common Stock · 1,957 shares Expires 2025-03-02 F1 · balance_after: On March 2, 2015, the reporting person was granted an award of 9,787 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 1,957 SARs which will vest on March 2, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.